The termination of refinancing discussions with the ad hoc lender group is the most significant signal — it suggests the company could not agree on terms, increasing the risk of a distressed outcome. Monitor for news of a new refinancing deal or potential restructuring. The Q1 results were in-line with guidance but the underlying business continues to shrink significantly YoY. The SEATW warrants trade on thin liquidity and could be highly volatile on any balance sheet news.
Price Chart
Executive Summary
Vivid Seats reported Q1 2026 revenue of $125.8M, slightly above the $124.5M consensus, but down 23% YoY from $164.0M. Adjusted EBITDA of $9.5M was at the high end of the $8-10M guidance range, though down 56% YoY from $21.7M. The company reaffirmed its full-year 2026 guidance of $2.2B-$2.6B Marketplace GOV and $30-40M Adjusted EBITDA. Critically, the 8-K also disclosed that confidential discussions with an ad hoc group of term loan lenders regarding a potential refinancing have ended, and the company is now actively negotiating with other lenders — a signal of ongoing balance sheet stress.
Key Financial Metrics
Key Facts
- Q1 2026 revenue of $125.8M, down 23% YoY from $164.0M
- Q1 2026 net loss of $14.6M, widened from $9.8M loss in Q1 2025
- Q1 2026 Adjusted EBITDA of $9.5M, down 56% from $21.7M in Q1 2025
- Marketplace GOV of $612.4M, down 25% YoY from $820.4M
- Full-year 2026 guidance reaffirmed: GOV $2.2B-$2.6B, Adj. EBITDA $30-40M
- Confidential refinancing discussions with ad hoc lender group terminated; company now negotiating with other lenders
- Cleansing Material disclosed 2027 guidance: GOV ~$2.65B, revenue ~$575M, Adj. EBITDA ~$45M
- Actioned $70M of annualized savings ($45M cash) through cost reduction program
- Shareholders' deficit of $95.4M as of March 31, 2026, worsened from $85.1M deficit at year-end 2025
- Cash balance improved to $143.6M from $102.7M at year-end 2025, driven by $46.0M operating cash flow
Financial Impact
Revenue decline of 23% YoY ($125.8M vs $164.0M); Adjusted EBITDA decline of 56% YoY ($9.5M vs $21.7M); net loss widened to $14.6M from $9.8M
Risk Factors
- Refinancing risk: failed negotiations with ad hoc lender group increase likelihood of unfavorable terms or restructuring
- Continued revenue decline of 23% YoY shows no stabilization in the core marketplace business
- Shareholders' deficit of $95.4M and accumulated deficit of $1.37B indicate deeply negative equity
- Full-year 2026 guidance implies H2 recovery that may not materialize given current trends
- Low market cap ($1M) and warrant structure create extreme volatility risk
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-018995 |
| Document: ef20072417_8k.htm | 0001140361-26-018995 |
| Document: ef20072417_ex99-2.htm | 0001140361-26-018995 |
| Document: 0001140361-26-018995-index-headers.html | 0001140361-26-018995 |
| Document: 0001140361-26-018995-index.html | 0001140361-26-018995 |
| Document: 0001140361-26-018995.txt | 0001140361-26-018995 |
| 8-K Data (Synthetic) | 0001140361-26-018995 |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access